Hit enter to search or ESC to close
Inceptua GroupInceptua GroupInceptua GroupInceptua Group
  • About
    • History
    • Mission
    • Quality
    • Leadership
    • Careers
  • Comparator Sourcing &
    Clinical Trial Services
  • Pre-approval &
    Unlicensed Medicines Access
    • For companies seeking support for access to their medicines
    • For physicians seeking access to unlicensed medicines
  • Inceptua
    Pharma
    • Jetrea®(ocriplasmin)
    • Farydak®(panobinostat)
  • News
    • Insights
    • News and Press Releases
  • Contact
    • General contacts
    • Partnering request
    • Medicines access requests
    • Safety and product complaints
    • Inceptua Pharma Access to Medicines Policy
  • IMAP Medicines Access Portal
  • 日本語
    Category

    Thought leadership

    Clinical Trial ServicesThought leadership

    Race the hurdles of global clinical trials

    Inceptua’s Edoardo Madussi shares his insights The case in favour of running a global clinical trial is compelling: lower running costs, quicker timelines, and access to substantially larger patient populations…
    Morten Grøn
    Morten GrønNovember 1, 2018
    Medicines AccessThought leadership

    What life science companies need to know about pre-approval access

    Pre-approval access is evolving at a rapid pace. Mark Corbett, Executive Vice President of Medicines Access at Inceptua, gives you an overview of the key benefits of utilizing pre-approval access…
    Mark Corbett
    Mark CorbettOctober 9, 2018

    © 2021 Inceptua Group.
    Contact | Privacy policy | Terms of use | Cookie policy
    Anti-slavery and Human trafficking statement | Company information

    • About
      • History
      • Mission
      • Quality
      • Leadership
      • Careers
    • Comparator Sourcing &
      Clinical Trial Services
    • Pre-approval &
      Unlicensed Medicines Access
      • For companies seeking support for access to their medicines
      • For physicians seeking access to unlicensed medicines
    • Inceptua
      Pharma
      • Jetrea®(ocriplasmin)
      • Farydak®(panobinostat)
    • News
      • Insights
      • News and Press Releases
    • Contact
      • General contacts
      • Partnering request
      • Medicines access requests
      • Safety and product complaints
      • Inceptua Pharma Access to Medicines Policy
    • IMAP Medicines Access Portal
    • 日本語